| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.049 | 0.8 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.8 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |